US panel backs Novartis transplant drug -- FDA Reuters VX) drug to prevent rejection of transplanted kidneys, a Food and Drug Administration spokeswoman said on Monday. The panel voted 11-1 to urge FDA clearance ... Panel Recommends Everolimus in Kidney Transplant FDA Panel Recommends Agency OK Novartis Kidney Drug Advisory panel recommends everolimus tablets for approval |
